| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |